deltatrials
Completed PHASE2 NCT02737358

N-acetylcysteine for Tobacco Use Disorder

Evaluating N-acetylcysteine as a Pharmacotherapy for Tobacco Use Disorder

Sponsor: Medical University of South Carolina

Conditions Nicotine Dependence Smoking
Interventions N-acetylcysteine (NAC) Placebo
Updated 12 times since 2017 Last updated: Jul 31, 2020 Started: Aug 30, 2016 Primary completion: Aug 1, 2019 Completion: Oct 10, 2019

Listed as NCT02737358, this PHASE2 trial focuses on Nicotine Dependence and Smoking and remains completed. Sponsored by Medical University of South Carolina, it has been updated 12 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Sep 2020 — Jan 2021 [monthly]

    Completed PHASE2

  5. Dec 2019 — Sep 2020 [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

▶ Show 7 earlier versions

  1. Oct 2019 — Dec 2019 [monthly]

    Recruiting PHASE2

  2. Jul 2019 — Oct 2019 [monthly]

    Recruiting PHASE2

  3. Feb 2019 — Jul 2019 [monthly]

    Recruiting PHASE2

  4. Jun 2018 — Feb 2019 [monthly]

    Recruiting PHASE2

  5. Feb 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

  6. Feb 2017 — Feb 2018 [monthly]

    Recruiting PHASE2

  7. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medical University of South Carolina
  • National Institute on Drug Abuse (NIDA)
Data source: Medical University of South Carolina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Charleston, United States